Dr. Daniel J. Desalvo, MD
Pediatric Endocrinology (Pediatric Endocrinology Physician)
At a glance
- In the NPI registry since
- 2008
Licensed in Texas since 2015, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Endocrinology Physician primary
TX license Q4938 (first issued 2015; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 4 companies reported 26 payments worth $30,020 in total to this clinician.
| Genzyme Corporation | $12,317 |
|---|---|
| Sanofi-aventis U.S. LLC | $12,026 |
| Dexcom, Inc. | $3,106 |
| Insulet Corporation | $2,570 |
| Consulting Fee | $23,310 |
|---|---|
| Speaking at a medical education program | $3,106 |
| Travel and Lodging | $2,775 |
| Food and Beverage | $829 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sanofi-aventis U.S. LLC Jul 17, 2025 | Consulting Fee | $10,992 |
| Genzyme Corporation Oct 3, 2025 | Consulting Fee | $10,992 |
| Insulet Corporation Aug 6, 2025 | Consulting Fee OMNIPOD · Insulin Pump | $1,326 |
| Dexcom, Inc. Nov 18, 2025 | Speaking at a medical education program | $1,190 |
| Dexcom, Inc. Mar 4, 2025 | Speaking at a medical education program | $774 |
| Dexcom, Inc. Sep 3, 2025 | Speaking at a medical education program | $595 |
| Genzyme Corporation Oct 3, 2025 | Travel and Lodging travel to Nashville, TN · in-kind | $570 |
| Dexcom, Inc. Jun 10, 2025 | Speaking at a medical education program | $548 |
| Sanofi-aventis U.S. LLC Jul 16, 2025 | Travel and Lodging travel to Detroit, MI · in-kind | $459 |
| Insulet Corporation Dec 12, 2025 | Travel and Lodging OMNIPOD · Insulin Pump · travel to Dallas, TX | $418 |
All 18 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Insulet Corporation Dec 17, 2025 | Travel and Lodging OMNIPOD · Insulin Pump · travel to Dallas, TX | $20.00 |
| Insulet Corporation Dec 17, 2025 | Travel and Lodging OMNIPOD · Insulin Pump · travel to Dallas, TX | $17.50 |
| Insulet Corporation Dec 12, 2025 | Travel and Lodging OMNIPOD · Insulin Pump · travel to Dallas, TX | $418 |
| Insulet Corporation Dec 12, 2025 | Travel and Lodging OMNIPOD · Insulin Pump · travel to Dallas, TX | $305 |
| Insulet Corporation Dec 12, 2025 | Travel and Lodging OMNIPOD · Insulin Pump · travel to Dallas, TX | $246 |
| Dexcom, Inc. Nov 18, 2025 | Speaking at a medical education program | $1,190 |
| Genzyme Corporation Oct 4, 2025 | Travel and Lodging travel to Nashville, TN · in-kind | $305 |
| Genzyme Corporation Oct 3, 2025 | Consulting Fee | $10,992 |
| Genzyme Corporation Oct 3, 2025 | Travel and Lodging travel to Nashville, TN · in-kind | $570 |
| Genzyme Corporation Oct 3, 2025 | Travel and Lodging travel to Nashville, TN | $101 |
| Dexcom, Inc. Sep 3, 2025 | Speaking at a medical education program | $595 |
| Insulet Corporation Aug 6, 2025 | Consulting Fee OMNIPOD · Insulin Pump | $1,326 |
| Sanofi-aventis U.S. LLC Jul 17, 2025 | Consulting Fee | $10,992 |
| Sanofi-aventis U.S. LLC Jul 17, 2025 | Travel and Lodging travel to Detroit, MI · in-kind | $288 |
| Sanofi-aventis U.S. LLC Jul 16, 2025 | Travel and Lodging travel to Detroit, MI · in-kind | $459 |
| Sanofi-aventis U.S. LLC Jul 16, 2025 | Travel and Lodging travel to Detroit, MI | $45.74 |
| Dexcom, Inc. Jun 10, 2025 | Speaking at a medical education program | $548 |
| Dexcom, Inc. Mar 4, 2025 | Speaking at a medical education program | $774 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $255,291 in research payments for these studies, mostly to the institutions running them.
- Safety and Efficacy of the Omnipod 5 SmartAdjust 2.0 System Compared to the Omnipod 5 System in Individuals with Type 1 or Type 2 Diabetes
Insulet Corporation - CIP344 SUCCEED2
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.